Randomized Study to Evaluate Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With Mild COVID-19 Infection

NCT05074394 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped to be replaced with a different protocol

Conditions

COVID-19

Interventions

BIOLOGICAL: COVI-DROPS
DRUG: Placebo

Sponsor

Sorrento Therapeutics, Inc.